Fluvoxamine Starting Dose
The appropriate starting dose of fluvoxamine is 50 mg once daily at bedtime for adults, and 25 mg once daily at bedtime for children and adolescents (ages 8-17 years). 1
Adult Dosing
The FDA-approved starting dose for fluvoxamine in adults is 50 mg administered as a single daily dose at bedtime 1. This recommendation is consistent across multiple clinical guidelines for both depression and anxiety disorders 2, 3.
- Initial dose: 50 mg at bedtime
- Titration schedule: Increase in 50 mg increments every 4-7 days as tolerated
- Therapeutic range: 100-300 mg/day (doses >100 mg should be divided twice daily, with the larger dose at bedtime)
- Maximum dose: 300 mg/day 1
Research supports that while the effective dose range is 50-300 mg/day, higher doses (100-150 mg/day) show significantly better response rates (73.7%) compared to lower doses of 50-75 mg/day (47.1%) 4. However, starting at the lower 50 mg dose minimizes initial side effects, particularly gastrointestinal complaints like nausea 5, 6.
Pediatric Dosing (Ages 8-17)
For children and adolescents, the starting dose is 25 mg once daily at bedtime 1.
- Initial dose: 25 mg at bedtime
- Titration schedule: Increase in 25 mg increments every 4-7 days as tolerated
- Maximum dose in children ≤11 years: 200 mg/day
- Maximum dose in adolescents: 300 mg/day
- Divided dosing: Total daily doses >50 mg should be split into two doses, with the larger dose at bedtime 1
Important consideration: Female children may achieve therapeutic effect at lower doses than males 1.
Special Populations
Elderly or Hepatically Impaired Patients
Lower starting doses and slower titration are appropriate for elderly patients and those with hepatic impairment, as these populations demonstrate decreased clearance of fluvoxamine 1. While specific starting doses are not mandated in the FDA label, clinical judgment should guide dose reduction from the standard 50 mg starting dose.
Titration Strategy and Timeline
The evidence suggests a conservative approach to dose escalation:
- Start with a subtherapeutic "test" dose to assess tolerability, as initial adverse effects can include anxiety or agitation 7
- Increase doses slowly at 1-2 week intervals for shorter half-life SSRIs like fluvoxamine 7
- Most patients show >80% cumulative response by 6 weeks of treatment 4
- If no improvement occurs by 6 weeks at adequate doses, consider changing the treatment regimen 4
Critical Safety Considerations
Drug Interactions
Fluvoxamine has extensive drug-drug interaction potential due to its effects on multiple CYP450 enzymes (CYP1A2, CYP2C19, CYP2C9, CYP3A4, and CYP2D6) 7. Exercise particular caution when combining with:
- Alprazolam or triazolam (reduce benzodiazepine dose by 50%) 2
- Any MAOIs (contraindicated due to serotonin syndrome risk) 7
Discontinuation Syndrome
Fluvoxamine is associated with discontinuation syndrome, characterized by dizziness, nausea, sensory disturbances, and anxiety 7. Always taper gradually over 10-14 days rather than stopping abruptly 2, 1.
Monitoring
Close monitoring for suicidal thinking and behavioral activation is essential, especially during the first few months and after dose changes 3, 7. The FDA black-box warning applies to all patients through age 24 years 7.
Practical Dosing Algorithm
- Start: 50 mg at bedtime (25 mg for ages 8-17)
- Week 1: Assess tolerability
- Week 2: If tolerated, increase to 100 mg/day (50 mg twice daily or 100 mg at bedtime)
- Weeks 3-6: Continue titrating by 50 mg increments every 4-7 days as tolerated, targeting 100-150 mg/day for optimal response
- Week 6: If inadequate response at therapeutic doses, consider treatment modification
- Maintenance: Use lowest effective dose; most patients respond to 100-200 mg/day 4, 6, 8